The FDA has approved Kerendia® (finerenone) to reduce the risk of cardiovascular death, hospitalization for HF, and urgent HF visits.

HealthDay News — For adults with overweight or obesity, certain factors might influence weight loss after taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs), according to a study published ...

Cardiovascular health is affected by environmental pollution, including microplastics and nanoplastics that have entered the food chain.

Dr. Kellan E. Baker discusses how significant cuts to health care research and bans on gender-affirming care affect LGBTQ+ ...

Topline data were announced from a phase 3 trial that evaluated baxdrostat in patients with uncontrolled or treatment resistant hypertension.

PCOS was associated with an increased risk for vascular events including stroke among women with thrombotic disease, and a lower mean age.

The study cohort comprised 41,095 patients with SLE, including 19,631 who received THA and 21,464 who received TKA. Overall, 30-day readmission rates were 6.1% for THA and 4.8% for TKA. Readmission ...

Bedtime dosing with antihypertensive medication yields better nocturnal blood pressure control and improved circadian rhythm.

There is decreased risk of all-cause and CV mortality in patients with transthyretin amyloidosis with cardiomyopathy treated with vutrisiran.

COCPs were associated with improved obesity outcomes among patients with hyperandrogenic PCOS, but metformin added little benefit.

There is increased risk for major gastrointestinal bleeding with edoxaban vs VKA therapy in patients with atrial fibrillation following TAVR.

HealthDay News — Pharmacologic treatment of hypercholesterolemia falls short of U.S. and European guidelines, according to a study published online June 30 in the Journal of General Internal Medicine.